Our observations are in alignment with those seen previously in advanced ccRCC, which suggest that ICI remodels the TME through tissue-resident CD8+ T cell expansion14, thereby modifying the interplay between cancer and immune cell populations13. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.